Cargando…

1853. Relevance of Actinomyces Bacteremia

BACKGROUND: Actinomyces species are Gram-positive anaerobic bacilli colonizing the human oropharynx, gastrointestinal tract, and urogenital tract asso­ciated with a wide range of infections. The isolation of Actinomyces spp. from sterile clinical samples is regarded as significant. We reviewed the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Mamta, Arcobello, Jonathan T, Tanveer, Farah, Revankar, Sanjay, Bhargava, Asish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752796/
http://dx.doi.org/10.1093/ofid/ofac492.1482
_version_ 1784850815665569792
author Sharma, Mamta
Arcobello, Jonathan T
Tanveer, Farah
Revankar, Sanjay
Bhargava, Asish
author_facet Sharma, Mamta
Arcobello, Jonathan T
Tanveer, Farah
Revankar, Sanjay
Bhargava, Asish
author_sort Sharma, Mamta
collection PubMed
description BACKGROUND: Actinomyces species are Gram-positive anaerobic bacilli colonizing the human oropharynx, gastrointestinal tract, and urogenital tract asso­ciated with a wide range of infections. The isolation of Actinomyces spp. from sterile clinical samples is regarded as significant. We reviewed the risk factors, clinical features, and outcomes in patients with Actinomyces bacteremia. METHODS: We conducted a retrospective study of all inpatients with Actinomyces bacteremia from two tertiary care centers from 1/1/06 -9 /26/19 . Data were collected on demographic and clinical characteristics, co-morbidities, primary source of infection, treatment received and duration of therapy and outcomes. True bacteremia was defined as Actinomyces bacteremia with systemic manifestations of infection. RESULTS: A total of 82 cases of positive blood cultures were identified of which 33 were true bacteremia, based on clinical criteria among 19 females and 14 males ranging from 19-93 years (63.8 ±19.5). Majority of patients were blacks (70%). Clinical risk factors predominantly were diabetes mellitus (21%), chronic renal failure (18%) and active malignancy (12%). Majority of blood cultures were positive within 48 hrs. of admission 84.8%. Skin and soft tissue (27%) was the most common source followed by respiratory (15%), intrabdominal (15%), osteomyelitis (12%), odontogenic (6%), endovascular (6%) genitourinary (3%) and unknown source (16%). In 27 (81%) cases, bacteremia was isolated to species level: A.meyeri 8 (30%), A.odontolyticus 7 (26%), A.israelli 7 (26%), A.turicensis 4 (15%) and A.neuii 1 (4%). The infectious diseases service was consulted in 20 cases of true bacteremia. Duration of antibiotics ranged between 0-84 days (17.6 ±20.7). All-cause mortality during hospitalization was 24% (8). CONCLUSION: Not all Actinomyces bacteremia may be relevant and can represent transient bacteremia. Better awareness and involvement of infectious disease service is recommended in understanding of the clinical significance, to ensure appropriate therapy for patients thereby implementing antibiotic stewardship to improve antibiotic use and, patient safety and improve outcomes. Further research will help to identify the true significance of these isolates. DISCLOSURES: All Authors: No reported disclosures.
format Online
Article
Text
id pubmed-9752796
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97527962022-12-16 1853. Relevance of Actinomyces Bacteremia Sharma, Mamta Arcobello, Jonathan T Tanveer, Farah Revankar, Sanjay Bhargava, Asish Open Forum Infect Dis Abstracts BACKGROUND: Actinomyces species are Gram-positive anaerobic bacilli colonizing the human oropharynx, gastrointestinal tract, and urogenital tract asso­ciated with a wide range of infections. The isolation of Actinomyces spp. from sterile clinical samples is regarded as significant. We reviewed the risk factors, clinical features, and outcomes in patients with Actinomyces bacteremia. METHODS: We conducted a retrospective study of all inpatients with Actinomyces bacteremia from two tertiary care centers from 1/1/06 -9 /26/19 . Data were collected on demographic and clinical characteristics, co-morbidities, primary source of infection, treatment received and duration of therapy and outcomes. True bacteremia was defined as Actinomyces bacteremia with systemic manifestations of infection. RESULTS: A total of 82 cases of positive blood cultures were identified of which 33 were true bacteremia, based on clinical criteria among 19 females and 14 males ranging from 19-93 years (63.8 ±19.5). Majority of patients were blacks (70%). Clinical risk factors predominantly were diabetes mellitus (21%), chronic renal failure (18%) and active malignancy (12%). Majority of blood cultures were positive within 48 hrs. of admission 84.8%. Skin and soft tissue (27%) was the most common source followed by respiratory (15%), intrabdominal (15%), osteomyelitis (12%), odontogenic (6%), endovascular (6%) genitourinary (3%) and unknown source (16%). In 27 (81%) cases, bacteremia was isolated to species level: A.meyeri 8 (30%), A.odontolyticus 7 (26%), A.israelli 7 (26%), A.turicensis 4 (15%) and A.neuii 1 (4%). The infectious diseases service was consulted in 20 cases of true bacteremia. Duration of antibiotics ranged between 0-84 days (17.6 ±20.7). All-cause mortality during hospitalization was 24% (8). CONCLUSION: Not all Actinomyces bacteremia may be relevant and can represent transient bacteremia. Better awareness and involvement of infectious disease service is recommended in understanding of the clinical significance, to ensure appropriate therapy for patients thereby implementing antibiotic stewardship to improve antibiotic use and, patient safety and improve outcomes. Further research will help to identify the true significance of these isolates. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9752796/ http://dx.doi.org/10.1093/ofid/ofac492.1482 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Sharma, Mamta
Arcobello, Jonathan T
Tanveer, Farah
Revankar, Sanjay
Bhargava, Asish
1853. Relevance of Actinomyces Bacteremia
title 1853. Relevance of Actinomyces Bacteremia
title_full 1853. Relevance of Actinomyces Bacteremia
title_fullStr 1853. Relevance of Actinomyces Bacteremia
title_full_unstemmed 1853. Relevance of Actinomyces Bacteremia
title_short 1853. Relevance of Actinomyces Bacteremia
title_sort 1853. relevance of actinomyces bacteremia
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752796/
http://dx.doi.org/10.1093/ofid/ofac492.1482
work_keys_str_mv AT sharmamamta 1853relevanceofactinomycesbacteremia
AT arcobellojonathant 1853relevanceofactinomycesbacteremia
AT tanveerfarah 1853relevanceofactinomycesbacteremia
AT revankarsanjay 1853relevanceofactinomycesbacteremia
AT bhargavaasish 1853relevanceofactinomycesbacteremia